b

biote Corp
NASDAQ:BTMD

Watchlist Manager
biote Corp
NASDAQ:BTMD
Watchlist
Price: 6.57 USD -2.23% Market Closed
Market Cap: 356.2m USD
Have any thoughts about
biote Corp?
Write Note

biote Corp
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

biote Corp
Cost of Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
b
biote Corp
NASDAQ:BTMD
Cost of Revenue
-$57.9m
CAGR 3-Years
-9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cost of Revenue
-$27B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Cost of Revenue
-$11.4B
CAGR 3-Years
-6%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Pfizer Inc
NYSE:PFE
Cost of Revenue
-$17.5B
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Merck & Co Inc
NYSE:MRK
Cost of Revenue
-$14.8B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cost of Revenue
-$7.8B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-4%

See Also

What is biote Corp's Cost of Revenue?
Cost of Revenue
-57.9m USD

Based on the financial report for Dec 31, 2023, biote Corp's Cost of Revenue amounts to -57.9m USD.

What is biote Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-9%

Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for biote Corp have been -9% over the past three years .

Back to Top